Home > Riviste > Minerva Surgery > Fascicoli precedenti > Minerva Surgery 2021 February;76(1) > Minerva Surgery 2021 February;76(1):80-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Surgery 2021 February;76(1):80-9

DOI: 10.23736/S2724-5691.20.08395-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Postoperative outcomes, lymph node dissection and effects on costs among thoracotomy, video-assisted and robotic-assisted lobectomy for clinical stage I non-small cell lung cancer

Roberto GULLO 1, Carola M. GAGLIARDO 2 , Manuela PALAZZOLO 1, Calogero PORRELLO 1, Leonardo GULOTTA 3, Felice LO FASO 4, Gaspare GULOTTA 5

1 Department of Thoracic Surgery, Paolo Giaccone University Hospital, Palermo, Italy; 2 Department of Surgical, Oncological and Stomatological Sciences, Paolo Giaccone University Hospital, Palermo, Italy; 3 Department of General and Oncologic Surgery, Gaetano Martino University Hospital, Messina, Italy; 4 Department of Thoracic Surgery, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy; 5 Department of General and Emergency Surgery, Paolo Giaccone University Hospital, Palermo, Italy



BACKGROUND: Thoracotomy, video-assisted thoracoscopic surgery (VATS) and robotic assisted thoracoscopic surgery (RATS)-lobectomy are widely accepted procedures for the surgical treatment of clinical (c)stage I non- small cell lung cancer (NSCLC). In the current literature which procedure gives more benefits is still debated. We present a comparison between these three procedures in term of advantages and postoperative outcomes.
METHODS: A multicentric study about 259 lobectomies from 2013 to 2019: 128 patients underwent TL, 96 VATS and 35 RATS. Different variables were retrospectively analyzed among these three cohorts of patients with diagnosis of cStage I NSCLC.
RESULTS: Rate of major complications comparable in VATS, RATS and TL; Advantages for RATS in minor complications (TL 34.4% vs. VATS 18.75% vs. RATS 8.57%. P=0.0015), postoperative days in Intensive Care Unit, days to chest tube removal, length of postoperative hospitalization (P<0.0001) and number of lymph nodes dissected (P=0.0257). Operating times are shorter in VATS than RATS (P<0.05). Pain (NRS Scale) is comparable.
CONCLUSIONS: TL remains the conventional approach for stage II-IIIA(N2) NSCLC. RATS showed great advantages, but its higher operating time and costs, mostly, today don’t justify its adoption as gold standard for the surgical treatment of cStage I NSCLC, instead of VATS.


KEY WORDS: Pneumonectomy; Thoracotomy; Thoracic surgery, video-assisted; Robotic surgical procedures; Lung neoplasms

inizio pagina